Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Sep 19, 2025
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Award
Common Stock
2025-09-15$1.00/sh+25,000$25,000→ 8,668,695 total - Award
Convertible notes
2025-09-15+100,000→ 511,544 totalExercise: $1.00From: 2025-09-15Exp: 2025-10-17→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Represents interest paid on a convertible note
- [F2]The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust.
- [F3]Not applicable.
- [F4]Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share.